The Impact of Covid-19 Pandemic on Colorectal Cancer Prevention Due to Delays in Diagnosis: a Global Study

Colorectal Cancer Clinical Trial

— COVID_CRC  

Official title:

The Impact of Covid-19 Pandemic on Colorectal Cancer Prevention Due to Delays in Diagnosis: a Global Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04637893
• Other study ID #: 100
• Status: Completed
• Start date: December 16, 2020
• Est. completion date: March 31, 2021

Study information

• Verified date: June 2022
• Source: Istituto Clinico Humanitas
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Screening programs have been associated with a substantial reduction in colorectal cancer (CRC) mortality through endoscopic resection of preneoplastic lesions and detection of early-stage invasive cancers.

In March 2020, the World Health Organization declared as a pandemic the outbreak of coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2. Since then, the SARS-CoV-2 have never stopped spreading, causing an unprecedented situation with highly restrictive considerations to be adopted by the majority of countries worldwide.

Health-care facilities have been making an enormous effort to assist patients affected by COVID-19, while adopting measures to maintain a safe environment for patients and healthcare professionals. As a result, the usual workflow in endoscopy departments changed dramatically, leading to an increase in cancelled procedures, probably increasing the future burden of Colorectal Cancer due to delays in diagnosis.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1000
• Est. completion date: March 31, 2021
• Est. primary completion date: March 31, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

• patients who underwent colonoscopy between the 1st October 2020 and the 31st December 2020 (pandemic cohort)

• patients who underwent colonoscopy between the 1st October 2019 and the 31st December 2019 (pre-pandemic cohort)

Related Conditions & MeSH terms

• Colorectal Cancer
• Colorectal Neoplasms
• COVID-19

Intervention

Other:
• Colonoscopy
Pt. underwent colonoscopy

Locations

Country	Name	City	State
Italy	Endoscopy Unit, Humanitas Research Hospital	Rozzano	Milano

Sponsors (1)

Lead Sponsor	Collaborator
Istituto Clinico Humanitas

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Colorectal Cancer prevention	To investigate the impact of COVID-19 pandemic on Colorectal Cancer prevention on a global scale.	3 months